Pacer Advisors, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Pacer Advisors, Inc.
- $41.8 Billion
- Q3 2024
A detailed history of Pacer Advisors, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 2,593 shares of AMPH stock, worth $115,673. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,593
Previous 927
179.72%
Holding current value
$115,673
Previous $37,000
237.84%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AMPH
# of Institutions
286Shares Held
35.1MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$265 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$121 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$95.2 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$86.9 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$72 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.19B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...